
### [Orphanet:282196](http://www.orpha.net/ORDO/Orphanet_282196)
**Label:** Autoimmune polyendocrinopathy

**Subclasses:** [Orphanet:3453](http://www.orpha.net/ORDO/Orphanet_3453) (Autoimmune polyendocrinopathy type 1), [Orphanet:3143](http://www.orpha.net/ORDO/Orphanet_3143) (Autoimmune polyendocrinopathy type 2), 

**Corr. equiv. classes:** [OMIM:269200](http://purl.obolibrary.org/obo/OMIM_269200), [Orphanet:3143](http://www.orpha.net/ORDO/Orphanet_3143), [OMIM:240300](http://purl.obolibrary.org/obo/OMIM_240300), [Orphanet:3453](http://www.orpha.net/ORDO/Orphanet_3453), 

**Class expressions from DL-Learner:**

- [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) and [HP:0100651](http://purl.obolibrary.org/obo/HP_0100651) (Type I diabetes mellitus) 62.50%
- [HP:0100646](http://purl.obolibrary.org/obo/HP_0100646) (Thyroiditis) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0100326](http://purl.obolibrary.org/obo/HP_0100326) (Immunologic hypersensitivity) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0011772](http://purl.obolibrary.org/obo/HP_0011772) (Abnormality of thyroid morphology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0011767](http://purl.obolibrary.org/obo/HP_0011767) (Abnormality of the parathyroid physiology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0011733](http://purl.obolibrary.org/obo/HP_0011733) (Abnormality of adrenal physiology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0011362](http://purl.obolibrary.org/obo/HP_0011362) (Abnormal hair quantity) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%
- [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0100647](http://purl.obolibrary.org/obo/HP_0100647) (Graves disease) 62.50%


